Sernova Biotherapeutics Company Description

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada.

The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions.

Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability.

The comoany was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025.

Sernova Biotherapeutics Inc is headquartered in London, Canada.

Sernova Biotherapeutics Inc

Country	Canada
Founded	1998
Industry	Biotechnology
Sector	Healthcare
Employees	17
CEO	Jonathan M. Rigby

Contact Details

Address: 700 Collip Circle London, British Columbia N6G 4X8 Canada
Phone	519 858 5184
Website	sernova.com

Stock Details

Ticker Symbol	SVA
Exchange	Toronto Stock Exchange
Fiscal Year	November - October
Reporting Currency	CAD
ISIN Number	CA81732W1041
SIC Code	2836

Key Executives

Name	Position
Jonathan M. N. Rigby M.B.A., MBA	Chief Executive Officer and Director
James T. Parsons CPA-CA, MAcc	Chief Financial Officer
Dr. Frank Shannon M.D.	Senior Vice President of Clinical Development and Regulatory Affairs
Dr. Modestus Obochi M.B.A., Ph.D.	Chief Business Officer
David Burke	Vice President of Investor Relations
Marylyn Rigby	Chief Communications Officer
Dr. Pericles Calias Ph.D.	Chief Development Officer and Head of Research & Development